CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-24 | HIGGINS JOHN L Director | Grant or award · Stock Option (right to buy) | +2,011 | 2,011 | ||
| 2019-10-24 | BAUMGARTNER ROBERT V Director | Grant or award | +495 | 9,221 | ||
| 2019-10-24 | BAUMGARTNER ROBERT V Director | Grant or award · Stock Options (right to buy) | +2,011 | 2,011 | ||
| 2019-09-09 | Kummeth Charles R. Chief Executive Officer | Purchase | +100 | $185.00 | $19K | 100 |
| 2019-09-09 | Kummeth Charles R. Chief Executive Officer | Purchase | +100 | $185.00 | $19K | 100 |
| 2019-08-19 | Eansor Norman David SVP - Novus Biologicals | Option exercise | +2,287 | 2,287 | ||
| 2019-08-19 | Eansor Norman David SVP - Novus Biologicals | Shares withheld for taxes | −900 | $197.57 | $178K | 1,387 |
| 2019-08-19 | Eansor Norman David SVP - Novus Biologicals | Option exercise · Restricted Stock Units | −2,287 | 0 | ||
| 2019-08-19 | Hippel James Chief Financial Officer | Option exercise | +4,925 | 9,307 | ||
| 2019-08-19 | Hippel James Chief Financial Officer | Shares withheld for taxes | −2,424 | $197.57 | $479K | 6,883 |
| 2019-08-19 | Hippel James Chief Financial Officer | Option exercise · Restricted Stock Units | −4,925 | 0 | ||
| 2019-08-19 | Kummeth Charles R. Chief Executive Officer | Option exercise | +24,979 | 135,856 | ||
| 2019-08-19 | Kummeth Charles R. Chief Executive Officer | Option exercise · Restricted Stock Units | −24,979 | 0 | ||
| 2019-08-19 | Furlow Brenda S. SVP - General Counsel | Option exercise | +1,759 | 3,948 | ||
| 2019-08-19 | Furlow Brenda S. SVP - General Counsel | Shares withheld for taxes | −745 | $197.57 | $147K | 3,203 |
| 2019-08-19 | Furlow Brenda S. SVP - General Counsel | Option exercise · Restricted Stock Units | −1,759 | 0 | ||
| 2019-08-13 | Kummeth Charles R. Chief Executive Officer | Option exercise | +7,410 | $67.46 | $500K | 110,877 |
| 2019-08-13 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −7,410 | 57,590 | ||
| 2019-08-07 | BAUMGARTNER ROBERT V Director | Purchase | +500 | $191.06 | $96K | 8,726 |
| 2019-08-07 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Restricted Stock Units | +3,151 | 3,151 |
Page 50 of 53 · 1,043 trades